Literature DB >> 5696468

Malaria prophylaxis and immunosuppressant therapy in management of nephrotic syndrome associated with quartan malaria.

J W Kibukamusoke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5696468      PMCID： PMC2020025          DOI： 10.1136/adc.43.231.598

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  5 in total

1.  Clinical and hematologic study of 6[(1-methyl-4-nitro-5-imidazolyl)thio]-purine (B.W.57-322) and related compounds.

Authors:  R W RUNDLES; J LASZLO; T ITOGA; J B HOBSON; F E GARRISON
Journal:  Cancer Chemother Rep       Date:  1961-10

2.  The nephrotic syndrome in Uganda and its association with quartan malaria.

Authors:  J W Kibukamusoke; M S Hutt; N E Wilks
Journal:  Q J Med       Date:  1967-07

3.  Some immunological studies of the nephrotic syndrome of Nigerian children.

Authors:  J F Soothill; R G Hendrickse
Journal:  Lancet       Date:  1967-09-23       Impact factor: 79.321

4.  Histological features of the nephrotic syndrome associated with quartan malaria.

Authors:  J W Kibukamusoke; M S Hutt
Journal:  J Clin Pathol       Date:  1967-03       Impact factor: 3.411

5.  The nephrotic syndrome in Lagos, Nigeria.

Authors:  J W Kibukamusoke
Journal:  West Afr Med J       Date:  1966-12
  5 in total
  3 in total

1.  A controlled trial of cyclophosphamide and azathioprine in Nigerian children with the nephrotic syndrome and poorly selective proteinuria.

Authors:  A Adeniyi; R G Hendrickse; J F Soothill
Journal:  Arch Dis Child       Date:  1979-03       Impact factor: 3.791

2.  Immunopathology of nephritis in Africa.

Authors: 
Journal:  Bull World Health Organ       Date:  1972       Impact factor: 9.408

3.  Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Robert P Baughman; Keith C Meyer; Ian Nathanson; Luis Angel; Sangeeta M Bhorade; Kevin M Chan; Daniel Culver; Christopher G Harrod; Mary S Hayney; Kristen B Highland; Andrew H Limper; Herbert Patrick; Charlie Strange; Timothy Whelan
Journal:  Chest       Date:  2012-11       Impact factor: 9.410
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.